113 related articles for article (PubMed ID: 9124184)
1. A phase II study of cisplatin, 5-fluorouracil, leucovorin, and etoposide in advanced non-small-cell lung cancer.
Rixe O; Coeffic D; Orcel B; Maitre B; Borel C; Benhammouda A; Petit T; Khayat D; Derenne JP
Am J Clin Oncol; 1997 Apr; 20(2):128-31. PubMed ID: 9124184
[TBL] [Abstract][Full Text] [Related]
2. Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B.
Vokes EE; Lyss AP; Herndon JE; Cooper B; Perry MC; Vinciguerra V; Mason-Coughlin K; Green MR
Ann Oncol; 1992 Nov; 3(9):727-32. PubMed ID: 1333267
[TBL] [Abstract][Full Text] [Related]
3. Continuous-infusion cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Lynch TJ; Kalish LA; Kass F; Strauss G; Elias A; Skarin A; Shulman L; Sugarbaker D; Frei E
Cancer; 1994 Feb; 73(4):1171-6. PubMed ID: 8313319
[TBL] [Abstract][Full Text] [Related]
4. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
[TBL] [Abstract][Full Text] [Related]
5. Concurrent 5-fluorouracil, leucovorin, etoposide, cisplatin and radiotherapy for locally advanced non-small cell lung cancer.
Yang CT; Chang WC; Chen LH; Leung WM; Lee CH; Liaw CC
Changgeng Yi Xue Za Zhi; 1997 Sep; 20(3):187-94. PubMed ID: 9397609
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of cisplatin, etoposide, and 5-fluorouracil in advanced non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study (PB586).
Kucuk O; Shevrin DH; Pandya KJ; Bonomi PD
Am J Clin Oncol; 2000 Aug; 23(4):371-5. PubMed ID: 10955866
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L
J Infus Chemother; 1996; 6(1):43-6. PubMed ID: 8748007
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group.
Crino L; Tonato M; Darwish S; Meacci ML; Corgna E; Di Costanzo F; Buzzi F; Fornari G; Santi E; Ballatori E
Cancer Chemother Pharmacol; 1990; 26(1):52-6. PubMed ID: 2157554
[TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
11. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
Chi KH; Chan WK; Shu CH; Law CK; Chen SY; Yen SH; Chen KY
Cancer; 1995 Dec; 76(11):2186-92. PubMed ID: 8635020
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
Vokes EE; Schilsky RL; Weichselbaum RR; Guaspari A; Guarnieri CM; Whaling SM; Panje WR
Cancer; 1989 Mar; 63(6 Suppl):1048-53. PubMed ID: 2783881
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer.
Lynch TJ; Kass F; Kalish LA; Elias AD; Strauss G; Shulman LN; Sugarbaker DJ; Skarin A; Frei E
Cancer; 1993 May; 71(10):2953-7. PubMed ID: 8387871
[TBL] [Abstract][Full Text] [Related]
14. Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer.
Chi KH; Chao Y; Chan WK; Lo SS; Chen SY; Yen SH; Chen KY; Wu CW; Lee SD; Lui WY
Br J Cancer; 1998 Jun; 77(11):1984-8. PubMed ID: 9667679
[TBL] [Abstract][Full Text] [Related]
15. Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.
Langer CJ; Curran WJ; Keller SM; Catalano R; Fowler W; Blankstein K; Litwin S; Bagchi P; Nash S; Comis R
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):469-78. PubMed ID: 8390421
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus.
Polee MB; Kok TC; Siersema PD; Tilanus HW; Splinter TA; Stoter G; Van der Gaast A
Anticancer Drugs; 2001 Jul; 12(6):513-7. PubMed ID: 11459997
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of mitomycin C, etoposide, and cisplatin in advanced non-small cell lung cancer.
Ali MA; Kraut MJ; Valdivieso M; Wozniak AJ; Cummings G; Kalemkerian GP
Cancer Invest; 2000; 18(1):1-5. PubMed ID: 10701360
[TBL] [Abstract][Full Text] [Related]
19. The effects of two different cisplatin-based chemotherapy regimens on advanced non-small cell lung cancer.
Chen CH; Yang CT; Chang WJ; Liaw CC; Tsao TC
Changgeng Yi Xue Za Zhi; 1999 Jun; 22(2):220-6. PubMed ID: 10493026
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant etoposide, ifosfamide, and cisplatin followed by concomitant thoracic radiotherapy and continuous cisplatin infusion in stage IIIb non-small cell lung cancer.
Pujol JL; Lafontaine T; Quantin X; Reme-Saumon M; Cupissol D; Khial F; Michel FB
Chest; 1999 Jan; 115(1):144-50. PubMed ID: 9925076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]